Super Lysine Plus Coldstick 70 mg/g
Octinoxate and Oxybenzone · LIPSTICK · Quantum, Inc.
Super Lysine Plus Coldstick is a lipstick containing octinoxate and oxybenzone at 70 mg/g, taken topical. Manufactured by Quantum, Inc..
Key Facts
- Brand Name
- Super Lysine Plus Coldstick
- Generic Name
- Octinoxate and Oxybenzone
- NDC Code (Product)
70084-220- Manufacturer
- Quantum, Inc.
- Strength
- 70 mg/g
- Dosage Form
- LIPSTICK
- Route
- TOPICAL
- Marketing Status
- Application #
- M020
- Marketing Start
- 01/06/1997
Recall History
No Recall HistoryFrequently Asked Questions
What is Super Lysine Plus Coldstick used for?
Super Lysine Plus Coldstick contains Octinoxate and Oxybenzone. It is a lipstick taken topical. Consult your doctor for specific uses.
Is Super Lysine Plus Coldstick a controlled substance?
Super Lysine Plus Coldstick is not classified as a controlled substance by the DEA.
What is the generic name for Super Lysine Plus Coldstick?
The generic name for Super Lysine Plus Coldstick is Octinoxate and Oxybenzone. There are 11 other brand versions of Octinoxate and Oxybenzone.
What is the NDC code for Super Lysine Plus Coldstick 70 mg/g?
The NDC (National Drug Code) for Super Lysine Plus Coldstick 70 mg/g is 70084-220, listed by Quantum, Inc..
Other Octinoxate Brands
See all →- ESIKA HYDRACOLOR 2 IN 1 Highly Moisturizing and coloring SPF 25 (ROSA ROMANTICA FEMME) - PINK.066 g/g13537-937
- Neutrogena Revitalizing Lip Balm SPF 20 - Soft Caramel 5075 mg/g69968-0252
- Neutrogena Revitalizing Lip Balm SPF 20 - Petal Glow 4075 mg/g69968-0254
- Lip Clear Lysine Plus Coldstick70 mg/g70084-210
- Petroleum-Free Lip Balm2 g/100g53329-092
- Marcelle CC Cream Complete Correction Sunscreen Broad Spectrum SPF 352.25 g/30mL69922-001
- ESIKA HYDRACOLOR 2 IN 1 SPF 25 (FUCSIA CAUTIVANTE EXOTIC) - PINK.0664 g/g13537-697
- Land Shark SPF 84.5 g/100mL52854-908
- Land Shark SPF 85 g/100mL52854-928
- Super Lysine Plus Tangerine Lip Treatment70 mg/g70084-230
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)